Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,317 | -7,279 | -3,563 | -13,905 | -10,727 |
| Depreciation Amortization | 505 | 324 | 162 | 649 | 487 |
| Other Working Capital | -207 | -64 | 316 | -1,519 | -1,975 |
| Other Operating Activity | 204 | 95 | 29 | 852 | 735 |
| Operating Cash Flow | $-9,815 | $-6,925 | $-3,056 | $-13,923 | $-11,480 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -458 |
| Common Stock Issued | 7,505 | 7,505 | 1,654 | 4,999 | 4,999 |
| Other Financing Activity | -408 | -292 | -179 | -482 | 0 |
| Financing Cash Flow | $7,097 | $7,213 | $1,474 | $4,518 | $4,541 |
| Exchange Rate Effect | 18 | 6 | N/A | -3 | -31 |
| Beginning Cash Position | 6,923 | 6,923 | 6,923 | 16,331 | 16,331 |
| End Cash Position | 4,224 | 7,217 | 5,341 | 6,923 | 9,361 |
| Net Cash Flow | $-2,699 | $294 | $-1,582 | $-9,408 | $-6,970 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,815 | -6,925 | -3,056 | -13,923 | -11,480 |
| Free Cash Flow | -9,815 | -6,925 | -3,056 | -13,923 | -11,480 |